Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

ClinicalTrials.gov ID: NCT00631007

Public ClinicalTrials.gov record NCT00631007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of INT131 Besylate Compared to Pioglitazone in Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 24 week study comparing the efficacy of four dose levels of INT131 besylate with pioglitazone HCl in patients with type 2 diabetes. Eligible patients will be men and women (of non-childbearing potential or using dual barrier methods of contraception) between 30 and 75 years of age who are minimally responsive to treatment with sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy.

Study identification

NCT ID
NCT00631007
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
InteKrin Therapeutics, Inc.
Industry
Enrollment
367 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jul 31, 2009
Completion
Aug 31, 2009
Last update posted
Sep 12, 2010

2008 – 2009

United States locations

U.S. sites
59
U.S. states
23
U.S. cities
51
Facility City State ZIP Site status
Northern California Research Carmichael California 95608
National Research Institute Los Angeles California 90057
VA San Diego Healthcare System San Diego California 92161
Apex Research Institute Santa Ana California 92705
Internal Medicine of the Rockies Colorado Springs Colorado 80910
Creekside Endocrine Associates, PC Denver Colorado 80209
Clinical Research Consulting, LLC Milford Connecticut 06460
MedStar Research Institute Washington D.C. District of Columbia 20003
Clinical Research of South Florida Coral Gables Florida 33134
The Center for Diabetes and Endocrine Care Hollywood Florida 33021
Baptist Diabetes Associates, PA Miami Florida 33156
International Research Associates, LLC Miami Florida 33156
Elite Research Institute Miami Florida 33169
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Suncoast Clinical Research, Inc. Palm Harbor Florida 34652
Meridien Research Tampa Florida 33606
Meridien Research Tampa Florida 34203
Clinical Research of Central Florida Winter Haven Florida 33880
Executive Health and Research Associates, Inc. Atlanta Georgia 30342
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Cedar-Crosse Research Center Chicago Illinois 60607
ICCT Reseach International Chicago Illinois 60611
American Health Network Indianapolis Indiana 46254
L-Marc Research Center Louisville Kentucky 40213
New Orleans Center for Clinical Research New Orleans Louisiana 70119
Stephen R. Smith, MD Baltimore Maryland 21234
Olive Branch Family Medical Center Olive Branch Mississippi 38654
Diabetes and Endocrinology Specialists, Inc. Chesterfield Missouri 63017
Saint Luke's Lipid and Diabetes Reseach Center Kansas City Missouri 64111
Bozeman Deaconess Internal Medicine Associates Bozeman Montana 59715
Comprehensive Clinical Research Berlin New Jersey 08009
Kaleida Health Diabetes Center Buffalo New York 14209
UNC Diabetes Care Center/Highgate Specialty Center Durham North Carolina 27713
Fairbrook Medical Clinic Hickory North Carolina 28602
Diabetes & Endrocrinology Consultants Morehead City North Carolina 28557
The Lindner Clinical Trial Center Cincinnati Ohio 45219
IVA Research Cincinnati Ohio 45245
Rapid Medical Research, Inc Cleveland Ohio 44122
Opitmed Research, LTD Columbus Ohio 43235
ResEvo LLC Cuyahoga Falls Ohio 44223
Delaware Smith Clinic Delaware Ohio 43015
Prestige Clinical Research Franklin Ohio 45005
Wells Institute for Health Awareness Kettering Ohio 45429
Frederick C Smith Clinic Marion Ohio 43302
Your Diabetes Endocrine Nutrition Group, LLC Mentor Ohio 44060
Clinical Research Source, Inc Perrysburg Ohio 43551
Tri-State Medical Group, Inc. Beaver Pennsylvania 15009
Lycoming Internal Medicine, Inc. Jersey Shore Pennsylvania 17740
New England Center for Clinical Research Cranston Rhode Island 02920
Hartwell Research Group Anderson South Carolina 29621
Medical Research South Charleston South Carolina 29407
Palmetto Clinical Trial Services, LLC Simpsonville South Carolina 29681
Dallas Diabetes and Endocrine Research Center Dallas Texas 75230
Research Institute of Dallas Dallas Texas 75231
Baylor University Endocrine Center Dallas Texas 75246
Diabetes Center of the Southwest Midland Texas 79705
Quality Research, Inc. San Antonio Texas 78209
DGD Research San Antonio Texas 78229
Salem VA Medical Center R&D Office Salem Virginia 24153

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00631007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 12, 2010 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00631007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →